Key result
The ACE gene I/D polymorphism showed no significant association with systemic arterial hypertension across normotensive, non-obese, obese, and diabetic groups.
Why the study?
Variants of the ACE gene have been reported to increase hypertension risk, but their relationship with blood pressure across distinct hypertensive subgroups required verification.
Does the ACE gene I/D polymorphism associate with systemic arterial hypertension in different classes of hypertensive individuals?
Cross-Sectional (n=112)
Yes
Does the ACE gene I/D polymorphism associate with systemic arterial hypertension in different classes of hypertensive individuals?
The ACE gene I/D polymorphism was not associated with systemic arterial hypertension in this Brazilian cohort, suggesting environmental factors may play a more prominent role in the development of the condition.
Answers are grounded in this paper and cite their sources.
ACE I/D variants may link to BP in hypertensive subgroups; leaves open any clinical or predictive role.
Systemic arterial hypertension (SAH) is a multifactorial clinical condition characterized by high and sustained levels of blood pressure (BP). Some studies have reported that variants of the angiotensin-converting enzyme (ace) gene increase the risk of hypertension. The aim of this study was to verify the existence of the relationship between the insertion/deletion (I/D) polymorphism in the ACE gene and its genotypic variants with BP in four distinct groups of hypertensive individuals and also to genetically and epidemiologically characterize the investigated samples. The study was formed of 112 individuals arranged into the following groups: normotensive (control); hypertensive and non-obese; hypertensive and obese; and, hypertensive and with type 2 diabetes mellitus (T2DM). Epidemiological data and peripheral blood were collected from participants for DNA extraction and amplification by PCR (polymerase chain reaction). The allele (D=0.5446; I=0.4554) and genotype (DD =0.2411, ID =0.6071; II =0.1518) frequencies showed low genetic differentiation (Fst<0.05) and were outside the Hardy-Weinberg equilibrium (p<0.05). There was no significant difference between the groups (chi-square=4.4335; p=0.6174). There was no association of the D allele with SAH, reinforcing the hypothesis that environmental interferences are prevalent in the evolution of SAH.
No takes yet. Share an insight, caveat, or question.
Umburanas et al. (2019) conducted a cross-sectional in Systemic arterial hypertension (n=112). ACE gene I/D polymorphism vs. Normotensive controls was evaluated on Genotype frequency differences between groups (p=0.6174). The ACE gene I/D polymorphism showed no significant association with systemic arterial hypertension across normotensive, non-obese, obese, and diabetic groups.
Synapse has enriched 10 related papers. Consider them for comparative context: